Nebula Research & Development LLC Merus N.V. Transaction History
Nebula Research & Development LLC
- $1.08 Trillion
- Q1 2025
A detailed history of Nebula Research & Development LLC transactions in Merus N.V. stock. As of the latest transaction made, Nebula Research & Development LLC holds 7,381 shares of MRUS stock, worth $486,555. This represents 0.03% of its overall portfolio holdings.
Number of Shares
7,381
Previous 31,485
76.56%
Holding current value
$486,555
Previous $1.32 Billion
76.53%
% of portfolio
0.03%
Previous 0.16%
Shares
5 transactions
Others Institutions Holding MRUS
# of Institutions
194Shares Held
62.2MCall Options Held
355KPut Options Held
96.5K-
Wellington Management Group LLP Boston, MA4.72MShares$311 Million0.04% of portfolio
-
Commodore Capital LP New York, NY4.47MShares$295 Million18.43% of portfolio
-
Rtw Investments, LP New York, NY4.17MShares$275 Million2.88% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.37MShares$222 Million7.27% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.17MShares$209 Million3.38% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $3.02B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...